Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for c…
This bill (Close the Medigap Act of 2025) amends Medicare statute to change rules for Medicare supplemental (Medigap) policies. It requires guaranteed issue protections and bans preexisting-condition exclusions and certain pricing discrimination; strengthens medical loss ratio standards; directs NAIC review of benefit and pricing standards (including limits on age-based pricing and area-based premium variation); restores first-dollar Medigap options by removing a limiting subsection; expands consumer information on the Medicare Plan Finder; and requires annual public reporting of broker/agent payments by Medigap issuers.
Progressives emphasize coverage gains and anti-discrimination protections.
Relative to its intended legislative type, this bill is a substantive statutory package that is largely specific about legal changes, assigns responsibilities and timelines, and builds in consultation and reporting.
This bill (Close the Medigap Act of 2025) amends Medicare statute to change rules for Medicare supplemental (Medigap) policies.
It requires guaranteed issue protections and bans preexisting-condition exclusions and certain pricing discrimination; strengthens medical loss ratio standards; directs NAIC review of benefit and pricing standards (including limits on age-based pricing and area-based premium variation); restores first-dollar Medigap options by removing a limiting subsection; expands consumer information on the Medicare Plan Finder; and requires annual public reporting of broker/agent payments by Medigap issuers.
The bill phases in many changes beginning January 1, 2026, with full implementation required by January 1, 2031, and includes outreach and stakeholder consultation requirements.
Substantive consumer-protection changes are plausible in committee or as part of broader reform, but insurer resistance and Senate procedural hurdles reduce standalone bill prospects.
Relative to its intended legislative type, this bill is a substantive statutory package that is largely specific about legal changes, assigns responsibilities and timelines, and builds in consultation and reporting. It provides a clear legislative framework for altering Medigap guaranteed-issue rules, pricing constraints, MLRs, consumer-facing information, and broker disclosure.
Progressives emphasize coverage gains and anti-discrimination protections.
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize coverage gains and anti-discrimination protections.
Likely broadly supportive.
The bill expands access for people with preexisting conditions, restricts discriminatory pricing, increases insurer transparency, and restores first-dollar Medigap coverage.
It aligns with priorities for universal access and stronger consumer protections, though effects on premiums are uncertain.
Cautious support with reservations.
The bill improves transparency and consumer information and addresses discriminatory practices, but it creates regulatory changes that could raise costs or disrupt insurance markets.
The phase-in and NAIC consultation are useful mitigations.
Likely opposed.
The bill imposes new federal mandates on pricing, expands guaranteed issue, restores first-dollar coverage, and mandates reporting burdens, which are seen as regulatory overreach that could increase costs and shrink provider choice.
Concerned about undermining state insurance regulation.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Substantive consumer-protection changes are plausible in committee or as part of broader reform, but insurer resistance and Senate procedural hurdles reduce standalone bill prospects.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize coverage gains and anti-discrimination protections.
Substantive consumer-protection changes are plausible in committee or as part of broader reform, but insurer resistance and Senate procedur…
Relative to its intended legislative type, this bill is a substantive statutory package that is largely specific about legal changes, assigns responsibilities and timelines, and builds in consultation and reporting. It…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.